Discontinued — last reported Q3 '18
C.H. Robinson Worldwide Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 84.1% to $1.31M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 84.1%, from $8.23M to $1.31M. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.58M | $11.51M | $9.01M | $8.58M | $8.86M | $1.81M | $1.81M | $1.80M | $207.00K | $206.00K | $0.00 | $8.23M | $8.26M | $8.26M | $1.31M |
| QoQ Change | — | -0.6% | -21.7% | -4.8% | +3.2% | -79.5% | -0.1% | -0.7% | -88.5% | -0.5% | -100.0% | — | +0.4% | +0.0% | -84.1% |
| YoY Change | — | — | — | -25.9% | -23.0% | -79.9% | -78.9% | -79.7% | -88.6% | -88.6% | -100.0% | >999% | >999% | — | -84.1% |
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| NAST | $7.86M | $7.86M | $7.86M | $7.86M | $7.86M | $7.86M | $7.86M | $7.86M |
| Global Forwarding | $2.30M | $2.28M | $2.38M | $2.21M | $373.00K | $407.00K | $407.00K | $407.00K |
| Total | $207.00K | $206.00K | $0.00 | — | $8.23M | $8.26M | $8.26M | — |
All Other and Corporate, Global Forwarding, NAST were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.